Literature DB >> 16024799

ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation.

Remy Pedeux1, Sagar Sengupta, Jiang Cheng Shen, Oleg N Demidov, Shin'ichi Saito, Hitoshi Onogi, Kensuke Kumamoto, Stephen Wincovitch, Susan H Garfield, Mary McMenamin, Makoto Nagashima, Steven R Grossman, Ettore Appella, Curtis C Harris.   

Abstract

ING2 is a candidate tumor suppressor gene that can activate p53 by enhancing its acetylation. Here, we demonstrate that ING2 is also involved in p53-mediated replicative senescence. ING2 protein expression increased in late-passage human primary cells, and it colocalizes with serine 15-phosphorylated p53. ING2 and p53 also complexed with the histone acetyltransferase p300. ING2 enhanced the interaction between p53 and p300 and acted as a cofactor for p300-mediated p53 acetylation. The level of ING2 expression directly modulated the onset of replicative senescence. While overexpression of ING2 induced senescence in young fibroblasts in a p53-dependent manner, expression of ING2 small interfering RNA delayed the onset of senescence. Hence, ING2 can act as a cofactor of p300 for p53 acetylation and thereby plays a positive regulatory role during p53-mediated replicative senescence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024799      PMCID: PMC1190357          DOI: 10.1128/MCB.25.15.6639-6648.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

2.  DNA damage checkpoint kinase Chk2 triggers replicative senescence.

Authors:  Véronique Gire; Pierre Roux; David Wynford-Thomas; Jean-Marc Brondello; Vjekoslav Dulic
Journal:  EMBO J       Date:  2004-06-10       Impact factor: 11.598

3.  Disappearance of the telomere dysfunction-induced stress response in fully senescent cells.

Authors:  Christopher J Bakkenist; Rachid Drissi; Jing Wu; Michael B Kastan; Jeffrey S Dome
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

4.  Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses.

Authors:  Jianxiu Yu; Ian de Belle; Hongyan Liang; Eileen D Adamson
Journal:  Mol Cell       Date:  2004-07-02       Impact factor: 17.970

5.  Promoter-specific p53-dependent histone acetylation following DNA damage.

Authors:  Matthias D Kaeser; Richard D Iggo
Journal:  Oncogene       Date:  2004-05-13       Impact factor: 9.867

Review 6.  Hallmarks of senescence in carcinogenesis and cancer therapy.

Authors:  Jerry W Shay; Igor B Roninson
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

7.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a).

Authors:  Utz Herbig; Wendy A Jobling; Benjamin P C Chen; David J Chen; John M Sedivy
Journal:  Mol Cell       Date:  2004-05-21       Impact factor: 17.970

8.  p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels.

Authors:  N Gopalakrishna Iyer; Suet-Feung Chin; Hilal Ozdag; Yataro Daigo; De-En Hu; Massimiliano Cariati; Kevin Brindle; Samuel Aparicio; Carlos Caldas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-27       Impact factor: 11.205

9.  No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma.

Authors:  Gesche Tallen; Ines Kaiser; Sonja Krabbe; Ulrike Lass; Christian Hartmann; Günter Henze; Karl Riabowol; Andreas von Deimling
Journal:  Int J Cancer       Date:  2004-04-10       Impact factor: 7.396

10.  The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis.

Authors:  Igor Garkavtsev; Sergey V Kozin; Olga Chernova; Lei Xu; Frank Winkler; Edward Brown; Gene H Barnett; Rakesh K Jain
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  53 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

2.  ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.

Authors:  Audrey Mouche; Jérôme Archambeau; Charles Ricordel; Laura Chaillot; Nicolas Bigot; Thierry Guillaudeux; Muriel Grenon; Rémy Pedeux
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

3.  Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.

Authors:  Silvia S Borkosky; Mehmet Gunduz; Hitoshi Nagatsuka; Levent Bekir Beder; Esra Gunduz; Mahmoud A L Sheikh Ali; Andrea P Rodriguez; Mehmet Zeynel Cilek; Susumu Tominaga; Noboru Yamanaka; Kenji Shimizu; Noriyuki Nagai
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-08       Impact factor: 4.553

Review 4.  Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers.

Authors:  Gregory David
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

5.  Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Authors:  Kensuke Kumamoto; Elisa A Spillare; Kaori Fujita; Izumi Horikawa; Taro Yamashita; Ettore Appella; Makoto Nagashima; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

7.  WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway.

Authors:  Romuald Binet; Damien Ythier; Ana I Robles; Manuel Collado; Delphine Larrieu; Claire Fonti; Elisabeth Brambilla; Christian Brambilla; Manuel Serrano; Curtis C Harris; Rémy Pedeux
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

Review 8.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

Review 9.  Structural insight into histone recognition by the ING PHD fingers.

Authors:  Karen S Champagne; Tatiana G Kutateladze
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

10.  NMR assignments and histone specificity of the ING2 PHD finger.

Authors:  Pedro V Peña; Catherine A Musselman; Alex J Kuo; Or Gozani; Tatiana G Kutateladze
Journal:  Magn Reson Chem       Date:  2009-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.